[Clinical trials with 4-methyl-2-aminopyridine camphorsulfonate in the shock from recent infarct].
D006801:Humans; D009203:Myocardial Infarction; D010847:Picolines; D012769:Shock; D013566:Sympathomimetics
D010847:Picolines; D013566:Sympathomimetics; C015672:2-amino-4-picoline
MYOCARDIAL INFARCT; SHOCK; SYMPATHOMIMETICS